CM Kramm
Impact in
- Genetics top 10%
- Virus-based gene therapy research
-
- CAR-T cell therapy research
Papers in
- Genetics 4
- Virus-based gene therapy research 4
-
- Signaling Pathways in Disease 1
- Histone Deacetylase Inhibitors Research 1
- CRISPR and Genetic Engineering 1
- Co-authors
- E. Antonio Chiocca (2 shared papers)Maureen Chase (2 shared papers)X. O. Breakefield (1 shared paper)Efstathios Boviatsis (1 shared paper)Miguel Sena‐Esteves (1 shared paper)J.T. Efird (1 shared paper)Ming Wei (1 shared paper)Jungsun Park (1 shared paper)
- Journals
- Gene Therapy (1 paper)Klinische Pädiatrie (1 paper)PubMed (3 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
CM Kramm
5 papers receiving 337 citations
Peers
Comparison fields: 5 of 35
- Genetics 249
- Oncology 127
- Immunology 86
- Biotechnology 33
- Epidemiology 115
Countries citing papers authored by CM Kramm
This map shows the geographic impact of CM Kramm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CM Kramm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CM Kramm more than expected).
Fields of papers citing papers by CM Kramm
This network shows the impact of papers produced by CM Kramm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CM Kramm. The network helps show where CM Kramm may publish in the future.
Co-authors
The 22 scholars most cited alongside CM Kramm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. | 1994 | 143 |
| 2 | Vaccination for experimental gliomas using GM-CSF-transduced glioma cells. | 1998 | 85 |
| 3 | 1998 | 68 | |
| 4 | Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm. | 1996 | 41 |
| 5 | 2016 | 5 |
About CM Kramm
CM Kramm is a scholar working on Genetics, Molecular Biology, Epidemiology, Neurology and Animal Science and Zoology, having authored 5 papers that have together received 342 indexed citations. Recurring topics across this work include Virus-based gene therapy research (4 papers), Herpesvirus Infections and Treatments (2 papers), CAR-T cell therapy research (1 paper), Signaling Pathways in Disease (1 paper), Histone Deacetylase Inhibitors Research (1 paper), Animal Virus Infections Studies (1 paper), Cancer Research and Treatments (1 paper) and CRISPR and Genetic Engineering (1 paper). The work is most often cited by research in Genetics (249 citations), Oncology (127 citations), Immunology (86 citations), Biotechnology (33 citations) and Epidemiology (115 citations). CM Kramm has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include E. Antonio Chiocca, Maureen Chase, X. O. Breakefield, Efstathios Boviatsis, Miguel Sena‐Esteves, J.T. Efird, Ming Wei, Jungsun Park, Ulrich Herrlinger and Dianne M. Finkelstein. Their work appears in journals such as Gene Therapy, Klinische Pädiatrie and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.